Environmental Factors and the Gut Microbiome - Endocannabinoid Axis (eMECA)
The Influence of Host Environmental Factors on the Gut Microbiome - Endocannabinoid Axis in Metabolic and Mental Health
연구 개요
상태
정황
상세 설명
The gut microbiome and the endocannabinoid system (ECS) could be interacting together and influence local enteric and peripheral metabolic functions and mental health.
The association of some host environmental factors (e.g. age, metabolic status, dietary habits) with gut microbiota composition and function has been investigated but, to our knowledge, little is known about their influence on the ECS.
There is also a need to better understand the influence of these factors and the interplay between the gut microbiota and the ECS and their relationship with intestinal, metabolic and mental health.
The investigators therefore propose to fill this knowledge-gap in the general population of adults with various body composition, dietary habits and daily physical activity levels.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
Quebec
-
Québec, Quebec, 캐나다, G1V 0A6
- Institut sur la nutrition et les aliments fonctionnels - INAF
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Computer and internet access
- Understanding of written French
Exclusion Criteria:
- Intestinal pathologies
- Pregnancy or breast-feeding
- Recent significant weight variations
- Recent completion of antibiotic treatment
- Alcohol consumption over sex-specific recommendations
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: 생태 또는 커뮤니티
- 시간 관점: 유망한
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Evaluation of the influence of dietary habits assessed via Food Frequency Questionnaire (FFQ) on the relationship between gut microbiota composition and circulating endocannabinoids
기간: September 2018
|
FFQ items will be used to identify dietary habits by unsupervised clustering to evaluate their association with gut microbiota composition obtained from ribosomal RNA sequencing and plasma endocannabinoid (e.g.
Arachidonoylethanolamide, 2 arachidonoyl glycerol and their derivatives) concentrations.
|
September 2018
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Evaluation of the effect of adiposity assessed by Dual-energy X-ray Absorptiometry (DXA) scan on the relationship between gut microbiota composition and circulating endocannabinoids.
기간: September 2018
|
The effect of adiposity measured by DXA scan on the relationship between gut microbiota composition and diversity obtained from ribosomal RNA sequencing and plasma endocannabinoids (e.g.
Arachidonoylethanolamide, 2 arachidonoyl glycerol and their derivatives) will be investigated.
|
September 2018
|
|
Evaluation of the effect of fasting glycemia on the relationship between gut microbiota composition and circulating endocannabinoids.
기간: September 2018
|
The effect of fasting glycemia, used to infer metabolic status, on the relationship between gut microbiota composition and diversity obtained from ribosomal RNA sequencing and plasma endocannabinoids (e.g.
Arachidonoylethanolamide, 2 arachidonoyl glycerol and their derivatives) will be investigated.
|
September 2018
|
|
Evaluation of the effect of fasting triglyceridemia on the relationship between gut microbiota composition and circulating endocannabinoids.
기간: September 2018
|
The effect of fasting triglyceridemia, used to infer metabolic status, on the relationship between gut microbiota composition and diversity obtained from ribosomal RNA sequencing and plasma endocannabinoids (e.g.
Arachidonoylethanolamide, 2 arachidonoyl glycerol and their derivatives) will be investigated.
|
September 2018
|
공동 작업자 및 조사자
스폰서
수사관
- 수석 연구원: Alain Veilleux, PhD, Laval University
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .